Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 1,903

Document Document Title
WO/2022/148797A1
Process for preparing potassium oxalate which process comprises contacting potassium formate with a base catalyst at a temperature of from 140 to 260°C which base catalyst is a metal hydride.  
WO/2022/132694A1
A system for glucaric acid production, the system comprising: (a) a first input selected from the group consisting of glucuronolactone, a disaccharide feedstock, a cleaved starch, a disaccharide, glucuronic acid, or a combination thereof...  
WO/2022/106549A1
The present invention relates to salt forms of the following compound (I).  
WO/2022/107695A1
A method for producing barium titanyl oxalate, wherein barium titanyl oxalate is produced by mixing and reacting a solution containing oxalic acid (solution A) and a solution containing a titanium source and a barium source (solution B) ...  
WO/2022/108435A1
The present invention relates to a method for transforming phosphogypsum, a waste produced by the phosphate industry, into high value-added products, namely ammonium sulphate and calcium oxalate.  
WO/2022/101287A1
A method for generating a carboxylic acid from carbon dioxide (CO2), the method includes (a) feeding a gas stream having the CO2 to a first reactor having a base (MOH) to produce bicarbonate (MHCO3) and (b) feeding the MHCO3 generated in...  
WO/2022/092851A1
The present invention relates to a method for preparing a hydrocarbon double acid with a cyclic hydrocarbon oxidation catalyst, wherein, in the presence of a vanadium phosphate oxide-based catalyst and/or a cobalt manganese oxide-based c...  
WO/2022/069568A1
The present disclosure relates to a method for generating a hydrogel from a CO2 gas stream. The method for converting a CO2 gas stream comprising a CO2 into an ester, comprises the conversion of CO2 into a (COOH)2 preferably by passing t...  
WO/2022/058785A1
The invention relates to new olaparib oxalic acid cocrystals. The olaparib oxalic acid cocrystals vary in ratio from 1:1 to 2:3 olaparib: oxalic acid. In particular, the invention relates to a 2:3 olaparib oxalic acid cocrystal, a 1:1 ol...  
WO/2022/048662A1
Disclosed is a preparation method for a bio-based nylon 5X fiber material. The method comprises the following steps: 1) mixing a 1,5-pentanediamine mixed fermentation liquid and a dibasic acid for a polymerization reaction, obtaining a n...  
WO/2022/040377A1
The present disclosure relates to methods of preparing compounds of Formula (VII) and salts thereof, and relates to compounds and combinations useful for the preparation. The present disclosure also relates to compounds being prepared by...  
WO/2022/013767A1
A process for the purification of saturated linear aliphatic dicarboxylic acids, or mixtures thereof, obtained by biotechnological processes is described.  
WO/2022/014234A1
Provided is a method for recovering high-purity scandium by effectively reducing impurity content of obtained scandium oxalate and reducing variation in impurity content. The present invention is a method that is for recovering scandiu...  
WO/2021/251451A1
The present invention provides barium titanyl oxalate which makes it possible to obtain barium titanate that has a small particle size and that is highly crystalline. The present invention also provides a method for producing said barium...  
WO/2021/231556A1
Processes for the oxidation of carbohydrate dehydration products, such as furanics that can be oxidized to the bio-based monomer 2,5-furandicarboxylic acid (FDCA), are disclosed, according to which certain co-feeds, having been discovere...  
WO/2021/224303A2
According to a first aspect, the invention relates to a polyethylene-type polymer comprising methylene groups (CH2) and at least one functional group selected from group O-C(=O) and group O-C(=O)-O, the polyethylene-type polymer having a...  
WO/2021/224063A1
The invention relates to a simple and efficient metal-free method for oxidative cleavage of vic-diols, in particular those derived from fatty esters, to the corresponding carboxylic acids, using a cheap, safe and environmentally friendly...  
WO/2021/158666A1
The disclosure provides novel solid state forms of Compound (I) selected from Form B, citric acid cocrystal Form A, piperazine cocrystal Form A, urea cocrystal Form A, nicotinamide cocrystal Form A, nicotinamide cocrystal Form B, asparta...  
WO/2021/140868A1
Provided is a means for controlling the molecular weight of a polyalkylene carbonate, when reacting a carbon dioxide with an epoxide to obtain a polyalkylene carbonate. More specifically, provided is an organozinc catalyst which is obtai...  
WO/2021/127461A1
The present disclosure is directed synthetic methods for the preparation of 4-valyloxybutyric acid. The synthetic methods described herein employ a diverse array of protecting group strategies and reaction conditions. Additionally, the p...  
WO/2021/119223A1
The present disclosure encompasses Lemborexant: succinic acid, a solid state form thereof, processes for preparation thereof, and pharmaceutical compositions thereof.  
WO/2021/108288A1
The present disclosure relates to amorphous and crystalline forms of (R)-N-(4-chlorophenyl)-2-((1S,4S)-4-(6-fluoroquinolin-4-yl)c yclohexyl)propanamide and its salts/cocrystals, solvates, and/or hydrates, processes for their production, ...  
WO/2021/101867A1
The disclosure provides salts of (2R,6R)-hydroxynorketamine (HNK), wherein the salt is with an organic acid chosen from malonic acid, salicylic acid, ethane sulfonic acid, glycolic acid, stearic acid, or capric acid, and their crystal fo...  
WO/2021/079973A1
Provided is an onium salt represented by general formula (1). (In general formula (1), X is any n-valent organic group selected from the group consisting of an aromatic group having 6-50 carbon atoms, a heteroaromatic group having 4-50 c...  
WO/2021/060335A1
The present invention is characterized by comprising a step (hydrogenation step) for reacting 3-hydroxyadipic acid-3, 6-lactone with hydrogen in an aqueous solvent in the presence of a hydrogenation catalyst, and is able to produce adipi...  
WO/2021/056850A1
Provided are an eutectic crystal formed by apixaban and a carboxylic acid, and a preparation method therefor. The eutectic crystal comprises an apixaban/malonic acid eutectic crystal, an apixaban/D‐malate eutectic crystal, an apixaban/...  
WO/2021/027807A1
Disclosed is a method for preparing an azelaic acid. In particular, the preparation method does not use ozone. The above method for preparing an azelaic acid includes carrying out a decarboxylation reaction of tetracarboxylic acid in org...  
WO/2021/023803A1
The presently claimed invention relates to a continuous process for the preparation of dicarboxylic acids, especially a continuous process for the preparation of sebacic acid.  
WO/2021/016339A1
An improved chemical probe for the detection of the amino acid citrulline combines: 1) a reactive head formed of 1,3-dicarbonyl moiety that reacts with a citrulline side chain in an improved manner compared to currently used 1,2-dicarbon...  
WO/2021/010368A1
An Me element-substituted organic acid titanyl barium powder that is Me element-substituted organic acid titanyl barium in which some of the Ba sites are substituted by an Me element (Me represents at least one selected from Ca, Sr, and ...  
WO/2021/001457A1
The present invention relates to crystalline salt forms of (R)-2-amino-3-phenylpropylcarbamate and a process for their preparation. The invention also relates to a pharmaceutical composition comprising one or more of the crystalline salt...  
WO/2020/251613A1
There is disclosed a process for the production of dodecanedioic acid and 11- aminoundecanoic acid, comprising: (1) reacting castor oil with a primary or secondary amine to form a amide; (2) isomerizing the amide in the presence of a cat...  
WO/2020/242772A1
The present disclosure encompasses solid state forms of SAGE-217, in embodiments SAGE-217: Oxalic acid Co-crystal, processes for preparation thereof, and pharmaceutical compositions thereof.  
WO/2020/239568A1
There is disclosed a salt of Formula III, a method for manufacturing thereof as well as uses thereof. ( Formula III ), wherein X is H or OH, Y is H or a cation selected from the group consisting of Li, Na and K, is a single bond or a dou...  
WO/2020/214841A1
Salts of hexylamine, for example, hexylamine succinate and tri-hexylamine citrate and their method of production are described. The disclosure also relates to compositions comprises hexyalmine and the use of hexylamine for for reducing a...  
WO/2020/202096A1
Aspects of the present application relate to amorphous Filgotinib maleate, its solid dispersion with at least one pharmaceutically acceptable excipients and pharmaceutical compositions thereof. Further aspects relate to processes for the...  
WO/2020/196460A1
This carboxylic acid production method enables a carboxylic acid to be produced efficiently, the method comprising: a step (A) for filtering a carboxylic acid-containing fermentation liquid by passing the same through a nano-filtration m...  
WO/2020/191140A1
The present invention is directed to selinexor co-crystal forms; more particularly to two co-crystal forms with succinic acid as the coformer and a co-crystal form with vanillin as the coformer. The present disclosure is also related to ...  
WO/2020/156360A1
A cholinesterase inhibitor polymorph, wherein specifically disclosed are a succinic octahydroacridine polymorph, a corresponding crystal composition and pharmaceutical composition, and applications thereof. The compound succinic octahydr...  
WO/2020/150568A1
Methods for syntheses of organic acids from a-keto acids, including methods for syntheses of isotopically encriched organic acids from a-keto acids are disclosed. The isotopically enriched organic acids are useful, for example, in metabo...  
WO/2020/124467A1
The present application relates to the technical field of batteries, and relates to an oxalate material, a preparation method, a use, a lithium-ion battery cathode material and a lithium-ion battery. The oxalate material of the present a...  
WO/2020/132381A1
The present invention relates to co-crystals of the compound of formula (I), wherein the co-former molecule is succinic acid or citric acid, processes for the preparation of the co-crystal, pharmaceutical compositions thereof, and method...  
WO/2020/118003A1
Sebacic acid is described for use in compositions and methods for enhancing the sweetness and mouthfeel of a consumable containing a carbohydrate sweetener or flavoring.  
WO/2020/092906A1
Provided herein are co-crystals comprising Compound 1 and a coformer. Pharmaceutical compositions comprising the co-crystals and methods for treating, preventing and managing disease are also disclosed.  
WO/2020/067683A1
The present invention relates to a crystalline form of (+)-Cibenzoline succinate. The present invention is also related to a process for the preparation of (+)-Cibenzoline succinate with chiral purity greater than 99.9%. The present inve...  
WO/2020/069527A1
Compounds, compositions, and methods related to bioenergetic metabolism are provided. The compounds and compositions are suited to promote bioenergetic processes including cellular respiration and glycolytic flux and may be used to treat...  
WO/2020/049150A1
Herein are provided novel salts of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolid in-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxy late namely the oxalate salt (I) and the dibenzoyltartrate salt (II).  
WO/2020/050368A1
The purpose of the present invention is to provide: a method for preparing a Vilsmeier reagent, that can be carried out safely, easily, and at a low cost; and a method for producing an aromatic aldehyde or an aromatic ketone, a carboxyli...  
WO/2020/037164A1
Provided herein are free base crystalline forms, crystalline salts, and an amorphous salts of omecamtiv mecarbil.  
WO/2020/013310A1
A method for inhibiting odor formation that comprises contacting component (a) and water with a microorganism and thus reducing the amount of an odor substance produced by the microorganism, wherein, at the pH value of a composition comp...  

Matches 1 - 50 out of 1,903